Financial Health Assessment: JC Analytical Ltd

1. Financial Health Score: B+

Explanation: The patient possesses a robust constitution, characterized by a strong and steadily growing equity base. However, this positive assessment is tempered by a significant circulatory issue: a severe drop in cash reserves coupled with a heavy reliance on intercompany debtors. The business is fundamentally healthy, but its liquidity is currently dependent on the wider corporate group, presenting a conditional rather than robust state of financial wellness.

2. Key Vital Signs

• Net Assets (The Body Mass): £3,004,068 Net assets have grown consistently from £1.12M in 2016 to over £3M in 2025. This shows a patient that has been steadily building strength and retaining earnings over the long term, indicating underlying profitability.
• Cash at Bank (Blood Pressure): £127,033 This is the most alarming vital sign. Cash has plummeted from £728k in 2023 to £247k in 2024, and down further to £127k in 2025. This represents a severe drop in financial blood pressure, restricting the company's immediate flexibility and ability to respond to shocks.
• Intercompany Debtors (Circulatory Blockage): £2,870,858 Of the £3.32M owed to the business by debtors, a staggering £2.87M is categorized as "Amounts owed by group undertakings." This means the company is pumping its financial lifeblood into its parent company, NEOS Holdings Limited, and fellow subsidiaries rather than collecting cash from external customers.
• Current Ratio (Immune System): 7.78x On the surface, current assets (£3.55M) vastly exceed current liabilities (£456k), suggesting a highly robust immune system against short-term debts. However, because the bulk of these current assets are intercompany loans rather than liquid cash or trade debtors, this ratio masks the true, tighter liquidity position.
• Liabilities (Cholesterol): Decreasing Total liabilities have dropped from £694k in 2023 to £456k in 2025. The business is actively paying down its external debt, which is a positive sign of financial discipline.

3. Diagnosis

Robust Constitution with Intercompany Circulatory Strain

JC Analytical Ltd is a profitable, mature business with a strong net worth. The retained earnings in the profit and loss account (£3,003,068) prove that the company knows how to generate wealth over time.

However, the financial data reveals a classic symptom of a subsidiary company acting as a "cash cow" or internal bank for its parent group. The dramatic hemorrhage of cash from the business—coinciding with over £2.8M tied up in group undertakings—indicates that the profits generated by JC Analytical Ltd are being sucked up into the wider NEOS Holdings Limited group structure rather than being retained as liquid cash.

While the company's own external liabilities are low and well-managed, its financial health is deeply intertwined with the health of its parent. If the parent company or other group entities experience distress, the £2.87M owed to JC Analytical Ltd could become impaired, which would instantly write off nearly all of the company's net worth and leave it unable to meet its own obligations. Furthermore, the company holds bank loans secured by a "fixed and floating charge over all assets," meaning that external lenders have the first claim on the company's assets if things go wrong.

4. Recommendations

• Improve Cash Flow (Financial Blood Transfusion): Management should seek to formalize repayment schedules for the £2.87M intercompany debt. Releasing even a fraction of these funds will restore healthy cash reserves and ensure the company can meet its operational needs without relying on external debt.
• Monitor Group Health (Check the Host): Because the company's financial wellness is so heavily tied to group undertakings, stakeholders must routinely assess the financial health of NEOS Holdings Limited. A disease in the parent company will quickly spread to the subsidiary.
• Maintain Emergency Reserves (Build Immunity): With cash at just £127k and current liabilities of £456k (including £161k in bank loans and £148k in tax), the company has little room for error. Establishing a minimum cash reserve target will ensure the business can weather unexpected operational shocks.